Bowling Portfolio Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,696
Closed -$439K 337
2019
Q1
$439K Sell
8,696
-37
-0.4% -$2.18K 0.07% 303
2018
Q4
$518K Sell
8,733
-3,765
-30% -$243K 0.09% 282
2018
Q3
$823K Sell
12,498
-20,944
-63% -$1.22M 0.12% 259
2018
Q2
$1.69M Sell
33,442
-3,191
-9% -$166K 0.24% 169
2018
Q1
$1.93M Buy
36,633
+18,656
+104% +$930K 0.26% 134
2017
Q4
$835K Sell
17,977
-1,677
-9% -$70.6K 0.11% 258
2017
Q3
$795K Sell
19,654
-3,416
-15% -$124K 0.12% 253
2017
Q2
$782K Buy
23,070
+1,571
+7% +$48.5K 0.12% 247
2017
Q1
$624K Buy
21,499
+5,824
+37% +$177K 0.1% 247
2016
Q4
$515K Buy
15,675
+137
+0.9% +$4.11K 0.08% 231
2016
Q3
$490K Buy
+15,538
New +$451K 0.07% 231

Other funds holding EBS

Bowling Portfolio Management's EBS Position: Q2 2019 in Review

Bowling Portfolio Management sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 8,696 shares — an estimated $439K sold.

Bowling Portfolio Management first reported a position in EBS in Q3 2016 and held it in 11 quarters. The position peaked at $1.93M in Q1 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Bowling Portfolio Management reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Bowling Portfolio Management sold 8,696 Emergent Biosolutions shares in Q2 2019, an estimated $439K.
  • Bowling Portfolio Management first reported a position in Emergent Biosolutions in Q3 2016 and held it in 11 quarters.
  • Bowling Portfolio Management's Emergent Biosolutions position peaked at $1.93M in Q1 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Bowling Portfolio Management's 13F filing for Q2 2019, filed 25 Jul 2019.